(Q34186198)

English

Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

John Piedad

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hugh Rickards

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Frank M C Besag

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Andrea E Cavanna

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

319-335

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mechanisms of Action of Antiepileptic Drugs

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Diverse mechanisms of antiepileptic drugs in the development pipeline

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

The new antiepileptic drugs: scientific review

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Primidone is associated with interictal depression in patients with epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Treatment of depressive disorders in epilepsy patients

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Behavioural effects of the new anticonvulsants

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A comparison of rectal diazepam gel and placebo for acute repetitive seizures

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Rectal diazepam gel for treatment of acute repetitive seizures. The North American Diastat Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Felbamate monotherapy has stimulant-like effects in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Gabapentin as an antiepileptic drug in man

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A beneficial effect on mood in partial epilepsy patients treated with gabapentin

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Lamotrigine associated with insomnia

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: an open, prospective, long-term study.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Lamotrigine Versus Valproate Monotherapy—Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Quality of life improvement with conversion to lamotrigine monotherapy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Improved mood states with lamotrigine in patients with epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Clinical experience of marketed Levetiracetam in an epilepsy clinic-a one year follow up study

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychiatric adverse events during levetiracetam therapy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effect of levetiracetam on depression and anxiety in adult epileptic patients

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Oxcarbazepine improves mood in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effects of tiagabine monotherapy on abilities, adjustment, and mood.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Acute psychotic symptoms induced by topiramate

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Low-dose topiramate in adults with treatment-resistant partial-onset seizures

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Randomized, concentration-controlled trial of topiramate in refractory focal epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Topiramate and psychiatric adverse events in patients with epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Controlled trial of sodium valproate in severe epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Retrospective study of vigabatrin and psychiatric behavioural disturbances.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychiatric adverse events during vigabatrin therapy

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A Clinical Scale for the Self-assessment of Irritability

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Adverse drug reactions: definitions, diagnosis, and management

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A Rating Instrument For Anxiety Disorders

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

A SELF-RATING DEPRESSION SCALE

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychiatric syndromes related to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Genetic mapping in human disease

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Psychotropic effects of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Can antiepileptic drugs unmask a susceptibility to psychiatric disorders?

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Depression and epilepsy: A bidirectional relation?

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

Deep brain stimulation for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.2165%2F11599780-000000000-00000

21 January 2018

The impact of seizures and adverse effects on global health ratings

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychotropic effects of antiepileptic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin use in psychotic epileptic patients: report of a prospective pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An active-control trial of lamotrigine monotherapy for partial seizures

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gabapentin in generalized seizures

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in depression associated with partial epilepsy in patients treated with lamotrigine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methods for reliable longitudinal observation of behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid detection of major depression in epilepsy: a multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22393904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11599780-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

release_arcpxzbmufdhjbsnozxguko4aa

1 reference

https://api.fatcat.wiki/v0/release/arcpxzbmufdhjbsnozxguko4aa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34186198&oldid=2196362334"